Stay updated with breaking news from Single Pills. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: APONTIS PHARMA AG / Key word(s): Share BuybackAPONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052 23.06.2022 / 07:30 The issuer is solely responsible for the content of this announcement.APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegat...
DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA launches two new single pills - medium-term revenue potenti...
DGAP-News: APONTIS PHARMA AG / Key word: Product Launch APONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million 25.05.2022 / 07:30 The... | May 25, 2022
DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement APONTIS PHARMA continues strong profitable growth in Q1 202...
05.05.2022 APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights | APONTIS PHARMA AG | News | Nachricht | Mitteilung